Overview of the Cross-National Collaborative Panic Study
- 1 May 1988
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 45 (5), 407-412
- https://doi.org/10.1001/archpsyc.1988.01800290021003
Abstract
• The Cross-National Collaborative Panic Study is a two-phase multinational, multicenter controlled trial for the evaluation of drug treatment of panic disorder and associated agoraphobia. The First Phase compared alprazolam with placebo in a large sample of more than 600 subjects at eight centers—five in the United States, two in Canada, and one in Australia. the Second Phase compared alprazolam, imipramini hydrochioride, placebo in more than 1100 patients in 14 countries. The scientific background, aims and purposes, governance, and policies regarding statistical analyses and scientific presentations and publications are reviewed as background for the series of individual articles reporting detailed findings from the First Phase.Keywords
This publication has 11 references indexed in Scilit:
- The Value of Structured Clinical InterviewsArchives of General Psychiatry, 1988
- The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disordersJournal of Affective Disorders, 1988
- Classification of anxiety disorders: A critique of DSM-IIIJournal of Affective Disorders, 1986
- Does alprazolam, in contrast to diazepam, activate alpha2-adrenoceptors involved in the regulation of rat growth hormone secretion?Life Sciences, 1986
- The diagnostic validity of anxiety disorders and their relationship to depressive illnessAmerican Journal of Psychiatry, 1985
- Alprazolam, Amitriptyline, Doxepin, and Placebo in the Treatment of DepressionArchives of General Psychiatry, 1985
- Platelet-Activating Factor-Induced Aggregation of Human Platelets Specifically Inhibited by TriazolobenzodiazepinesScience, 1984
- Imipramine and Brief Therapist-Aided Exposure in Agoraphobics Having Self-exposure HomeworkArchives of General Psychiatry, 1983
- Treatment of Endogenous Anxiety With Phobic, Hysterical, and Hypochondriacal SymptomsArchives of General Psychiatry, 1980
- Delineation of two drug-responsive anxiety syndromesPsychopharmacology, 1964